PANAFCORTELONE SYRUP South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

panafcortelone syrup

adcock ingram limited - syrup - see ingredients - each 5,0 ml syrup contains prednisolone 15,0 mg

PANAFCORT Zimbabwe - English - Medicines Control Authority

panafcort

adcock ingram limited - prednisone - tablet; oral - 5mg

Panafcort Tablets Namibia - English - Namibia Medicines Regulatory Council

panafcort tablets

adcock ingram ltd - prednisone - tablet - prednisone tablet 5 mg

Locoid C ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

locoid c ointment

astellas pharma ltd - chlorquinaldol; hydrocortisone butyrate - cutaneous ointment - 30mg/1gram ; 1mg/1gram

Predmix Australia - English - Department of Health (Therapeutic Goods Administration)

predmix

aspen pharmacare australia pty ltd - prednisolone sodium phosphate -

METEX XR metformin hydrochloride 500 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

metex xr metformin hydrochloride 500 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, modified release - excipient ingredients: colloidal anhydrous silica; magnesium stearate; povidone; hypromellose - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin modified release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

METEX XR metformin hydrochloride 1000 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

metex xr metformin hydrochloride 1000 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - metformin hydrochloride, quantity: 1000 mg - tablet, modified release - excipient ingredients: hypromellose; povidone; magnesium stearate; colloidal anhydrous silica - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin modified release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.